Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Sleeman

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Biochemistry|August 6, 1998
CD44 variant exon v5 encodes a tyrosine that is sulphatedJ P Sleeman, U Rahmsdorf, A Steffen, et al.
Cancer Research|June 11, 1998
Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronateA C Gao, W Lou, J P Sleeman, et al.
Oncogene|December 22, 1999
Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitroL Sherman, J P Sleeman, R F Hennigan, et al.
Developmental Biology|January 27, 1998
Autonomous neural axis formation by ectopic expression of the protooncogene c-skiL S Amaravadi, A W Neff, J P Sleeman, et al.
Cell Death & Disease|October 5, 2013
Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44K Fuchs, A Hippe, A Schmaus, et al.
The Journal of Clinical Investigation|September 3, 1998
Two different functions for CD44 proteins in human myelopoiesisJ Moll, S Khaldoyanidi, J P Sleeman, et al.
Oncogene|August 12, 1999
Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen BJ P Sleeman, U Kim, J LePendu, et al.
Cancer Research|March 14, 2001
Gene expression patterns associated with the metastatic phenotype in rodent and human tumorsA Nestl, O D Von Stein, K Zatloukal, et al.
European Journal of Biochemistry|October 31, 2001
Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2V Kirkin, R Mazitschek, J Krishnan, et al.
Oncogene|June 26, 2001
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acidT Ahrens, J P Sleeman, C M Schempp, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Biochemistry|August 6, 1998
CD44 variant exon v5 encodes a tyrosine that is sulphatedJ P Sleeman, U Rahmsdorf, A Steffen, et al.
Cancer Research|June 11, 1998
Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronateA C Gao, W Lou, J P Sleeman, et al.
Oncogene|December 22, 1999
Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitroL Sherman, J P Sleeman, R F Hennigan, et al.
Developmental Biology|January 27, 1998
Autonomous neural axis formation by ectopic expression of the protooncogene c-skiL S Amaravadi, A W Neff, J P Sleeman, et al.
Cell Death & Disease|October 5, 2013
Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44K Fuchs, A Hippe, A Schmaus, et al.
The Journal of Clinical Investigation|September 3, 1998
Two different functions for CD44 proteins in human myelopoiesisJ Moll, S Khaldoyanidi, J P Sleeman, et al.
Oncogene|August 12, 1999
Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen BJ P Sleeman, U Kim, J LePendu, et al.
Cancer Research|March 14, 2001
Gene expression patterns associated with the metastatic phenotype in rodent and human tumorsA Nestl, O D Von Stein, K Zatloukal, et al.
European Journal of Biochemistry|October 31, 2001
Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2V Kirkin, R Mazitschek, J Krishnan, et al.
Oncogene|June 26, 2001
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acidT Ahrens, J P Sleeman, C M Schempp, et al.
Pageof 3